Celldex Therapeutics Cash Flow Statement (2010-2026) | CLDX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-13.37M-20.45M-20.15M-23.05M-36.00M-26.78M-26.49M-29.36M-30.50M-38.26M-43.31M-32.81M-35.84M-42.12M-47.09M-53.80M-56.60M-67.04M-81.32M-78.69M
Share-based Compensation (Quarter)
1.51M3.03M3.14M3.15M3.45M4.50M4.51M4.34M5.22M7.12M7.21M7.20M7.64M9.62M9.78M9.32M9.19M8.80M8.91M8.52M
Deferred Taxes (Quarter)
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)
1.34M4.13M-7.11M4.06M0.03M1.58M-0.00M0.03M1.53M1.07M6.38M6.16M2.47M0.11M-0.00M0.04M0.20M9.18M0.08M
Asset Writedowns and Impairment (Quarter)
3.50M
Non-cash Items (Quarter)
1.45M1.39M31.70M29.50M51.20M46.70M42.90M38.30M2.90M3.09M3.26M55.30M3.55M3.75M3.98M4.23M81.90M72.80M5.28M5.49M
Cash from Operations (Quarter)
-11.93M-16.37M-14.52M-24.53M-22.24M-35.19M-21.76M-28.57M-27.20M-18.99M-32.53M-40.64M-29.33M-55.34M-32.48M-54.37M-44.03M-48.60M-63.94M-65.60M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortizatization of Intangibles (Quarter)
0.12M3.23M-0.20M-0.77M-0.54M-0.06M0.52M1.26M1.16M1.63M2.18M3.31M4.74M4.33M3.36M2.27M1.69M1.02M0.88M0.63M
Depreciation & Amortization (CF) (Quarter)
0.76M0.75M0.78M0.81M0.74M0.67M0.67M0.73M0.76M0.77M0.76M0.78M0.80M0.79M0.82M0.87M0.87M0.82M0.82M0.85M
Change in Working Capital
Change in Receivables (Quarter)
-1.33M-0.24M-0.03M0.07M-0.15M0.09M0.16M0.97M-1.20M0.13M2.38M0.04M-1.14M-0.68M-0.15M0.36M-0.97M1.93M-1.78M
Change in Accured Expenses (Quarter)
0.52M-3.10M-0.55M-2.74M6.62M-3.17M2.01M-3.45M1.73M2.85M-0.66M-4.78M1.71M-1.73M16.43M-0.60M-6.03M13.06M4.60M-1.36M
Investing Activities
Capital Expenditures (Quarter)
0.14M0.18M0.35M0.57M0.67M0.34M0.23M0.58M0.41M0.16M0.67M0.34M0.27M0.55M0.76M0.27M0.73M0.44M1.28M1.64M
Sales of Property, Plant and Equipment (Quarter)
0.00M0.00M0.07M
Change in Acquisitions & Divestments (Quarter)
38.00M13.00M45.95M27.84M78.91M86.11M87.80M127.00M83.15M39.55M70.89M77.31M122.06M148.36M153.98M195.04M172.84M116.92M111.50M133.37M
Cash from Investing Activities (Quarter)
-13.91M-226.79M-18.94M10.38M25.28M23.07M31.21M52.57M1.16M11.65M-171.16M-315.21M-46.72M47.76M24.05M42.95M49.85M60.85M55.42M72.12M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
-0.03M2.00M0.43M0.30M0.07M2.31M1.40M0.69M0.13M0.26M215.14M432.30M-424.77M1.24M423.53M0.20M0.06M0.77M1.35M0.33M
Misc.
Cash from Financing Activities (Quarter)
-0.03M271.90M0.43M0.30M0.07M2.31M1.40M0.69M0.13M0.26M217.37M436.11M3.71M1.24M0.39M0.20M0.06M0.77M1.35M0.33M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
-25.87M28.74M-33.04M-13.85M3.11M-9.82M10.85M24.69M-25.90M-7.09M13.68M80.26M-72.34M-6.34M-8.04M-11.22M5.91M12.99M-7.17M6.86M
Free Cash Flow (Quarter)
-12.07M-16.56M-14.88M-25.11M-22.92M-35.54M-22.00M-29.15M-27.61M-19.15M-33.20M-40.98M-29.60M-55.88M-33.23M-54.64M-44.76M-49.05M-65.22M-67.24M
Net Cash Flow (Quarter)
-25.87M28.74M-33.04M-13.85M3.11M-9.82M10.85M24.69M-25.90M-7.09M13.68M80.26M-72.34M-6.34M-8.04M-11.22M5.88M13.02M-7.17M6.85M